Verapamil Hydrochloride Capsule, Delayed Release
Pricing Report NDC 52536-886-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Verapamil Hydrochloride (NDC 52536-886-01) is $8.04919 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Wilshire Pharmaceuticals, Inc., this medication is distributed in a 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$8.04919
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
100 EA
Estimated Package Price
$804.92
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
52536-886-01
Description
100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2025, the NADAC wholesale price for (NDC ) has moved within a range of $4.11307 to $8.45343 per EA. Over this 1 year and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.1131 - $8.4534
Market Volatility
105.53% Variance
Latest Trend
2.89%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $8.04919 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $8.28872 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $8.45343 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $8.35639 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $8.11425 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $8.15688 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $8.00239 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $7.65318 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $7.12785 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $5.55222 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $4.40260 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $4.42513 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $4.46425 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $4.43296 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $4.40180 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $4.30226 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 12, 2025 $4.11307 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026